High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype
Yoel Genaro Montoyo-Pujol(Instituto de investigación sanitaria y biomédica de Alicante), Gloria Peiró(Ludwig-Maximilians-Universität München)
Cited by 1
Related Papers
Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
|British Journal of Cancer|2014|94